Kiran Mahmood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kiran Mahmood has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Kirtipal Bhatia
Cardiology Division, Montefiore Health System/Albert Einstein College of Medicine, Bronx, NY (F.I.C.-Y., A.F., S.N., D.L., K.B., A.L.S., L.S., M.J.G.).
4 shared publications Aditya Parikh
Mount Sinai Fuster Heart Hospital, New York, New York
3 shared publicationsAnuradha Lala
Mount Sinai Fuster Heart Hospital, New York, New York
3 shared publications- Arman Qamar
Division of Interventional Cardiology and Vascular Medicine, Endeavor Health (NorthShore University HealthSystem), Glenbrook Hospital, Glenview, IL (A.Q.).
3 shared publications - Edo Y. Birati
The Lydia and Carol Kittner, Lea and Benjamin Davidai Division of Cardiovascular Medicine and Surgery. Cardiovascular Department, Tzafon Medical Center, Poriya, The Azrieli Faculty of Medicine, Bar Ilan University, Zefat, Israel, Israel
3 shared publications Estefania Oliveros
Zena and Michael A. Wiener Cardiovascular Institute (V.Q.C., G.G., K.M., E.O., E.N., N.M., S.S.M., J.P.C., L.C., G.S., A.G.P., A.L., M.G.T.,G.L., S.P.P., D.M.M.), Icahn School of Medicine at Mount Sinai, New York, NY
3 shared publications
Latest Publications
- 10 November 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (4) , 529-538
18F-FDG PET/CT in left ventricular assist device infections: In-depth characterization and clinical implications
- 10 November 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (4) , 529-538
18F-FDG PET/CT in left ventricular assist device infections: In-depth characterization and clinical implications
- Open Access
- 6 December 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (23)
Trends in Veno‐Arterial Extracorporeal Life Support With and Without an Impella or Intra‐Aortic Balloon Pump for Cardiogenic Shock
Background: Mechanical circulatory support devices, such as the intra‐aortic balloon pump (IABP) and Impella, are often used in patients on veno‐arterial extracorporeal life support (VA‐ECLS) with cardiogenic shock despite limited supporting clinical trial data. Methods and Results: Hospitalizations for cardiogenic shock from 2016 to 2018 were identified from the National Inpatient Sample. Trends in the use of VA‐ECLS with and without an IABP or Impella were assessed semiannually. Multivariable logistic regression and general linear regression evaluated the association of Impella and IABP use with in‐hospital outcomes. Overall, 12 035 hospitalizations with cardiogenic shock and VA‐ECLS were identified, of which 3115 (26%) also received an IABP and 1880 (16%) an Impella. Use of an Impella with VA‐ECLS substantially increased from 10% to 18% over this period ( P P P <0.001 each). Most (57%) IABPs or Impellas were placed on the same day as VA‐ECLS. After adjustment, there were no differences in in‐hospital mortality or length of stay with the addition of an IABP or Impella compared with VA‐ECLS alone. Conclusions: From 2016 to 2018 in the United States, use of an Impella and IABP with VA‐ECLS significantly increased. More than half of Impellas and IABPs were placed on the same day as VA‐ECLS, and the use of a second mechanical circulatory support device did not impact in‐hospital mortality. Further studies are needed to decipher the optimal timing and patient selection for this growing practice.
- 6 December 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (23)
Open AccessTrends in Veno‐Arterial Extracorporeal Life Support With and Without an Impella or Intra‐Aortic Balloon Pump for Cardiogenic Shock
Background: Mechanical circulatory support devices, such as the intra‐aortic balloon pump (IABP) and Impella, are often used in patients on veno‐arterial extracorporeal life support (VA‐ECLS) with cardiogenic shock despite limited supporting clinical trial data. Methods and Results: Hospitalizations for cardiogenic shock from 2016 to 2018 were identified from the National Inpatient Sample. Trends in the use of VA‐ECLS with and without an IABP or Impella were assessed semiannually. Multivariable logistic regression and general linear regression evaluated the association of Impella and IABP use with in‐hospital outcomes. Overall, 12 035 hospitalizations with cardiogenic shock and VA‐ECLS were identified, of which 3115 (26%) also received an IABP and 1880 (16%) an Impella. Use of an Impella with VA‐ECLS substantially increased from 10% to 18% over this period ( P P P <0.001 each). Most (57%) IABPs or Impellas were placed on the same day as VA‐ECLS. After adjustment, there were no differences in in‐hospital mortality or length of stay with the addition of an IABP or Impella compared with VA‐ECLS alone. Conclusions: From 2016 to 2018 in the United States, use of an Impella and IABP with VA‐ECLS significantly increased. More than half of Impellas and IABPs were placed on the same day as VA‐ECLS, and the use of a second mechanical circulatory support device did not impact in‐hospital mortality. Further studies are needed to decipher the optimal timing and patient selection for this growing practice.
- 21 February 2022
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 15 (4) , S52-S53
CRT-600.08 Contemporary Trends of Utilization of VA-ECMO Support With and Without Impella or Intra-Aortic Balloon Pump for Cardiogenic Shock in the United States 2016 to 2018
- 21 February 2022
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 15 (4) , S52-S53
CRT-600.08 Contemporary Trends of Utilization of VA-ECMO Support With and Without Impella or Intra-Aortic Balloon Pump for Cardiogenic Shock in the United States 2016 to 2018
- 1 October 2020
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 13 (10) , e007485
Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19
- 1 October 2020
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 13 (10) , e007485
Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19
- 1 October 2020
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 26 (10) , 900-901
Pulmonary Artery Pressure Monitoring during the COVID-19 Pandemic in New York City
- 1 October 2020
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 26 (10) , 900-901
Pulmonary Artery Pressure Monitoring during the COVID-19 Pandemic in New York City
- Open Access
- 1 July 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (9) , 1337-1341
Predisposition or Protection?
- 1 July 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (9) , 1337-1341
Open AccessPredisposition or Protection?
- Open Access
- 1 July 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (9) , 1315-1320
The Imperfect Cytokine Storm
- 1 July 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (9) , 1315-1320
Open AccessThe Imperfect Cytokine Storm
- 1 February 2018
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 24 (2) , 65-73
Dietary Nitrate Increases VO2peak and Performance but Does Not Alter Ventilation or Efficiency in Patients With Heart Failure With Reduced Ejection Fraction
- 1 February 2018
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 24 (2) , 65-73
Dietary Nitrate Increases VO2peak and Performance but Does Not Alter Ventilation or Efficiency in Patients With Heart Failure With Reduced Ejection Fraction